GenXys Inks Deal with Precision Genetics for Personalized Medicine

Vancouver’s GenXys Healthcare Systems has inked a deal with Precision Genetics that will see the company use GenXys’s software solutions to embed pharmacogenetics (PGx) and offer an improved and transformative approach to precision prescribing.

Precision prescribing has become a leading method to bring PGx closer to the standard of care for certain conditions that often carry a high cost and a lower rate of medication effectiveness.

Precision Genetics will use GenXys’s IdentifyPGx™, TreatGx™, and ReviewGx™ software solutions to enhance patient care, safety, and treatment effectiveness.

IdentifyPGx has already enabled Precision Genetics to effectively identify which patient populations will benefit most from PGx testing. This includes individuals who have an increased possibility of genetic variant involvement in the effectiveness and safety of their medication, patients with mental health or cardiovascular issues and/or those who are undergoing surgery.

This innovative, evidence-based population risk stratification analysis will be integrated with the GenXys’s clinical decision support software to deliver actionable treatment insights at any point-of-care. Through an up-to-date and automated system IdentifyPGx will make complex decisions straightforward and timely.

“Science has provided the power of PGx testing and clinical studies have proven the clinical benefit. What’s been missing is an accessible way to provide pharmacogenetic insights to the clinician so accurate prescribing can occur at any point of care quickly with confidence,” Karl Pringle, CEO of GenXys, commented.

“Because our software platform is laboratory and electronic health record agnostic, more health plans and health systems than ever before can bring the full value of PGx testing insights to more patients to improve treatment and reduce adverse drug reactions and events. We are pleased to partner with Precision Genetics to better understand the patient needs and maximize their health and wellness benefits from an evidence-based perspective.”